Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia

A case report and literature review

Authors

  • Mehrdad Payandeh Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Afshin Karami Department of Hematology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Noorodin Karami Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Jafar Barati Masgareh Department of Biology, School of Sciences, Razi University, Kermanshah, Iran

DOI:

https://doi.org/10.15419/bmrat.v5i8.465

Keywords:

Immune thrombocytopenia, Prednisolone, Primary ITP, Romiplostim, Splenectomy

Abstract

Immune thrombocytopenia is characterized by reduced platelet count. This condition occurs in both adults and children. The most common form of thrombocytopenia is primary ITP and autoantibodies are involved in its development. In this study, our patient was a pregnant woman with ITP who showed refractory to prednisolone and splenectomy as first and second line treatment, respectively, but the response to treatment with Romiplostim and platelet count was favorable, and delivery was reported without fetal complications.

Author Biography

  • Noorodin Karami, Department of Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
    Noorodin.karami@yahoo.com

Published

2018-08-23

Issue

Section

Case report

How to Cite

Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia: A case report and literature review. (2018). Biomedical Research and Therapy, 5(8), 2565-2571. https://doi.org/10.15419/bmrat.v5i8.465